WHO Antimicrobial Resistance in Nigeria is an important area of focus in the country’s efforts to understand prevent and control antimicrobial resistance (AMR). Antimicrobial medicines have transformed healthcare by making many infections treatable. However microorganisms can develop resistance to these medicines making infections more difficult to manage.
The World Health Organization (WHO) works with countries including Nigeria to strengthen their ability to monitor antimicrobial resistance improve laboratory systems promote responsible antimicrobial use and develop effective public health responses. These efforts are particularly important as Nigeria continues to strengthen its national approach to AMR.
Understanding Antimicrobial Resistance
Antimicrobial resistance occurs when microorganisms such as bacteria viruses fungi and parasites develop the ability to survive medicines that are intended to control or eliminate them.
Antibiotic resistance is one of the most common examples. When bacteria become resistant to antibiotics medicines that once worked against an infection may no longer be effective.
AMR can develop naturally but inappropriate and excessive use of antimicrobial medicines can accelerate the process. Taking antibiotics when they are not needed using the wrong medicine or using antimicrobials incorrectly can contribute to the development and spread of resistance.
This makes AMR a public health issue that requires coordinated action.
Why WHO Antimicrobial Resistance in Nigeria Matters
The importance of WHO Antimicrobial Resistance in Nigeria goes beyond international cooperation. WHO support can help strengthen the systems Nigeria needs to identify resistance and respond to it effectively.
AMR surveillance is particularly important because healthcare professionals need reliable information about resistant microorganisms and changing resistance patterns.
Without good data it can be difficult to understand the scale of the problem or determine which treatments are likely to work.
By supporting surveillance and technical capacity international and national public health organizations can help Nigeria make more informed decisions about antimicrobial treatment and policy.
The Importance of AMR Surveillance
AMR surveillance is the systematic collection and analysis of information about antimicrobial resistance.
It can help answer important questions:
- Which microorganisms are becoming resistant?
- Which antibiotics remain effective?
- Where are resistant infections being detected?
- Are resistance patterns changing over time?
- How is antimicrobial use affecting resistance?
The answers to these questions can support doctors laboratories hospitals policymakers and public health authorities.
For Nigeria reliable surveillance data can help identify emerging resistance threats and support the development of appropriate treatment recommendations.
WHO’s Role in Supporting Nigeria
The WHO provides technical guidance and support to countries working to strengthen their AMR response.
In Nigeria this support is connected to areas such as surveillance laboratory capacity antimicrobial stewardship infection prevention and national AMR planning.
WHO also promotes standardized approaches to collecting and reporting AMR information. Consistent methods make it easier to understand resistance patterns and compare information across healthcare settings.
This type of collaboration can help Nigeria strengthen its public health infrastructure while contributing information to the wider global understanding of AMR.
Strengthening Laboratory Capacity
Laboratories are at the center of effective AMR surveillance.
When a patient has a suspected bacterial infection laboratory testing can help identify the microorganism responsible. Additional testing can determine whether the organism is susceptible or resistant to specific antibiotics.
Without adequate laboratory capacity surveillance data may be incomplete.
Nigeria’s efforts to strengthen laboratory networks training quality systems and diagnostic capacity are therefore important components of the AMR response.
Better laboratories can help healthcare professionals make more informed treatment decisions while providing valuable data for surveillance.
The Role of Antimicrobial Stewardship
AMR surveillance is closely connected to antimicrobial stewardship.
Antimicrobial stewardship aims to ensure that medicines are used appropriately. This means selecting the most suitable antimicrobial when treatment is necessary and using the correct dose route and duration.
Stewardship also encourages healthcare professionals to review treatment as additional clinical or laboratory information becomes available.
If testing shows that a narrower antibiotic is appropriate treatment can potentially be adjusted. If evidence indicates that antimicrobial treatment is unnecessary it may be stopped under professional guidance.
These practices can improve patient care and help reduce unnecessary antimicrobial exposure.
Infection Prevention and AMR
Preventing infections is another important part of the AMR response.
If fewer people develop infections fewer people require antimicrobial medicines. Effective infection prevention can also reduce the spread of resistant microorganisms within healthcare facilities and communities.
Important measures include hand hygiene vaccination environmental cleaning safe injection practices appropriate sterilization sanitation and effective infection prevention and control programs.
Healthcare facilities need strong infection prevention systems especially when treating patients with resistant infections.
WHO’s work on AMR therefore connects closely with broader efforts to improve infection prevention and control.
The Importance of Responsible Antibiotic Use
Antibiotics are valuable medicines but they should not be treated as a solution for every illness.
Many common infections are caused by viruses against which antibiotics are not effective.
Unnecessary antibiotic use exposes bacteria to these medicines and can contribute to resistance.
Patients should avoid using antibiotics without appropriate professional advice. They should also avoid sharing medicines or using leftover antibiotics for a new illness.
Healthcare professionals can help by explaining why a particular medicine is or is not necessary and by encouraging patients to follow appropriate treatment instructions.
WHO and Nigeria’s National AMR Response
Nigeria has been developing and implementing national strategies to address antimicrobial resistance.
The country’s AMR response involves multiple sectors and is aligned with a One Health approach. This recognizes that antimicrobial resistance can affect humans animals agriculture food systems and the environment.
WHO can support national efforts by providing technical guidance tools expertise and opportunities for collaboration.
National ownership remains essential however. Sustainable progress depends on Nigeria’s health institutions professionals laboratories policymakers researchers and communities working together.
The One Health Approach
AMR cannot be solved by focusing only on hospitals.
Antimicrobial use in animals and agriculture can influence resistance. Resistant microorganisms can also move between people animals food systems and the environment.
The One Health approach encourages different sectors to share information and coordinate their activities.
For Nigeria this means bringing together human health professionals veterinarians agricultural experts environmental specialists researchers laboratories policymakers and communities.
This broader approach can help identify risks that might otherwise be missed.
Challenges in Tackling AMR in Nigeria
Nigeria faces several challenges in its AMR response.
Access to diagnostic services can vary between healthcare settings. Some facilities may have limited laboratory resources while communities may experience barriers to accessing qualified healthcare professionals.
Awareness of appropriate antimicrobial use also needs to continue improving.
Other challenges include the need for stronger surveillance networks consistent data reporting adequate funding trained personnel and effective implementation of stewardship programs.
Addressing these challenges requires long-term commitment and collaboration.
How AMR Surveillance Can Improve Healthcare
Strong surveillance can directly support patient care.
When healthcare professionals understand local resistance patterns they can make more informed decisions about empirical treatment.
Hospitals can also use surveillance information to develop antimicrobial guidelines that reflect local conditions.
At the national level resistance data can help policymakers identify priorities for investment and intervention.
Surveillance can also reveal emerging threats before they become widespread allowing public health authorities to respond more effectively.
In this way surveillance is not simply about collecting numbers. It is about turning reliable information into better healthcare decisions.
The Role of NNAST
The Nigerian National Antimicrobial Stewardship TaskForce has an important role in strengthening antimicrobial stewardship in Nigeria.
By bringing together professionals from different areas of healthcare stewardship efforts can be better coordinated and aligned with national AMR priorities.
NNAST’s work complements broader national and international efforts by promoting responsible antimicrobial use professional collaboration awareness and improved stewardship practices.
Collaboration among national institutions healthcare professionals laboratories researchers and international organizations is essential for creating sustainable progress.
What Can Healthcare Professionals Do?
Healthcare professionals can contribute to the AMR response in several practical ways.
Prescribers can use antimicrobial medicines only when clinically appropriate and review treatment when new information becomes available.
Pharmacists can support appropriate dispensing and patient education.
Laboratory professionals can provide accurate diagnostic and susceptibility information.
Nurses and infection prevention teams can help reduce the spread of infections through appropriate healthcare practices.
Continuous professional education can ensure that healthcare workers remain aware of changing resistance patterns and current stewardship principles.
What Can the Public Do?
The public is also part of the solution.
Patients should seek appropriate medical advice before taking antibiotics and should avoid purchasing or using antibiotics simply because they have symptoms such as fever or cough.
People should not share antibiotics with others or save leftover medicines for future illnesses.
Communities can also support infection prevention through good hygiene vaccination sanitation and appropriate healthcare-seeking behavior.
Public awareness campaigns can help people understand that protecting antibiotics is a shared responsibility.
Conclusion
WHO Antimicrobial Resistance in Nigeria represents an important part of the country’s broader effort to strengthen AMR surveillance improve healthcare and protect the effectiveness of antimicrobial medicines.
WHO support can contribute technical guidance surveillance approaches laboratory strengthening and opportunities for collaboration. However sustainable progress depends on strong national action and continued cooperation across healthcare and other sectors.
Nigeria’s response to AMR should continue to focus on reliable surveillance stronger diagnostic services antimicrobial stewardship infection prevention responsible medicine use and public education.
The challenge is significant but progress is possible. When healthcare professionals laboratories policymakers researchers organizations and communities work together Nigeria can strengthen its ability to detect antimicrobial resistance and respond to it effectively.
Protecting antimicrobial medicines today means protecting essential treatment options for patients tomorrow.
